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For personalSummary Background/objective: Although many studies have demonstrated similar periop-
erative outcomes for single-incision laparoscopic surgery (SILS) and conventional laparoscopic
surgery (CLS) for colon cancer, few have directly compared the costs of them. We aimed to
compare costs between SILS and CLS for colon cancer.
Methods: We analyzed the clinical outcomes and overall hospital costs of patients who under-
went laparoscopic surgery for colon cancer from July 2009 to September 2014 at our institu-
tion; 288 were used for analysis after propensity score matching. The total hospital charge,
including fees for the operation, anesthesia, preoperative diagnosis, and postoperative man-
agement was analyzed.
Results: The total hospital charges were similar in both groups ($8770.40 vs. $8352.80,
P Z 0.099). However, the patients’ total hospital bill was higher in the SILS group than in
the CLS group ($4184.82 vs. $3735.00, P < 0.001) mainly due to the difference of the cost
of access devices. There was no difference in the additional costs associated with readmission
due to late complications between the two groups ($2383.08 vs. $2288.33, P Z 0.662). Incre-
mental cost-effectiveness ratio for total incision length in ‘total hospital charge’ and patient’s
bill and government’s bill in ‘cost of instruments and supplies’ were -$107.08/1 cm, -$109.70/
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Minimally invasive surgery (MIS), including laparoscopic
surgery (LS) and robotic surgery, has shown to have
acceptable short- and long-term outcomes in the context of
various diseases.1e3 LS is an option for colorectal cancer
based on the similar or even superior results associated
with the procedure compared with those of open surgery
for colorectal malignancies.4e6 Novel techniques, such as
natural orifice transluminal endoscopic surgery or single-
incision laparoscopic surgery (SILS), have been developed
to meet surgeons’ efforts to maximize the advantages of
MIS and the patients’ desires to reduce scarring and pain.
SILS, which is characterized by only one surgical incision,
has been suggested as an option for treating colorectal
malignancies. SILS for colon cancer has shown comparable
oncologic outcomes, as well as a shorter total incision
length, when compared with conventional laparoscopic
surgery (CLS).7e10 However, it has several limitations as an
alternative treatment option for colorectal cancer,
including patient selections, technical difficulties, and
questionable cost-effectiveness.11,12
Therefore, recent studies of SILS for colorectal cancer
have attempted to clarify the learning curve for both LS-
experienced surgeons and novices, to expand the in-
dications for SILS, and more comfortable technical tips,
whereas prior studies have primarily focused on the safety
and feasibility of the procedure.13,14 However, to date
there has been no cost-effectiveness study of SILS for colon
cancer, and only a few studies having reported the costs
associated with the procedure. The aim of the current
study was to focus on the comparative costs of SILS versus
CLS for colon cancer. We compared the costs of SILS with
those of CLS, subdividing the total hospital charges into five
categories.
2. Methods
2.1. Patients
We retrospectively reviewed the medical records of the
patients who underwent SILS and CLS for colon cancer at
Severance Hospital, Yonsei University College of Medicine,
Seoul, Korea between July 2009 and September 2014. The
institutional review board approved the study before the
clinical data collection was performed. All patients signed
an informed consent form after receiving information
regarding both surgical methods from their surgeon,
including the possibility of a difference in costs. The colon
was defined as the large intestine from the cecum to the User (n/a) at Yonsei University College of
e only. No other uses without permission. Crectosigmoid junction; those patients with rectal cancer
were excluded from this study. Patients with synchronous
or recurrent colon cancer and patients who received
emergency surgery for perforation, obstruction, or bleeding
were also excluded.
Two surgeons with experience in CLS performed SILS and
CLS, and two additional surgeons performed CLS only. SILS
required only one surgical incision using an Octo port
(Dalim Medical, Seoul, Korea), whereas CLS necessitated
three or four incisions and a minilaparotomy to retrieve the
colon. All surgeons used one energy device and two or three
linear or circular staplers, according to the type of surgery
performed (anterior resection or right hemicolectomy). The
length of incision was calculated by the sum of all incision
lengths. Details of these surgical techniques are described
in our previous reports.10,15 The patients’ baseline char-
acteristics and perioperative outcomes were compared
between the two groups. Postoperative complications were
considered early when they occurred within 30 days of
surgery, and late when they occurred between 30 days
after the surgery to February 2018, the final follow-up date.
The additional costs due to early complications were
included in the hospitalization and analyzed, whereas the
additional costs incurred by late complications were
analyzed separately.
2.2. Costs
The total hospital charges in this study were composed of
fees for the operation, anesthesia, preoperative diagnosis,
postoperative management, and other costs (Fig. 1). Each
of these costs was divided into insured charges (ICs) and
noninsured charges (NICs), in accordance with the reim-
bursement scheme of the Korean National Health Insurance
Corporation (NHIC), a government organization. During the
study period, the NHIC paid 95% of all ICs for patients who
had a malignancy for 5 years from their date of diagnosis;
this was the government’s bill. The patient’s bill in this
study was therefore the sum of 5% of the ICs and 100% of
the NICs.
The operation fees included the surgery and treatment
fees, plus the cost of instruments and supplies. The surgery
and treatment fees included the cost of surgery; the use of
the operating room; compensation for the doctors and
nurses who participated in the surgery; and the cost of
urinary catheter insertion, aseptic dressings, nasogastric
tube insertion, and other procedures. The surgery and
treatment fees for SILS and CLS were the same, but the
costs differed according to whether an anterior resection or
right hemicolectomy was performed. The ICs associated
with right hemicolectomies and anterior resections Medicine from ClinicalKey.com by Elsevier on April 06, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
Figure 1 Health care costs for surgical patients in Korea.
Cost of single-incision laparoscopy for colon cancer 559(sigmoid colectomies) gradually increased from $958.62 and
$1067.19 in January 2009 to $1125.60 and $1171.01 in
December 2014, respectively. The costs of instruments
differed according to the number and type of laparoscopic
access devices used, and those were thus different be-
tween SILS and CLS. The cost of a trocar for CLS was
approximately $115.60, for which patients would pay only
5% ($5.78) because the NHIC had approved trocars as an IC.
By contrast, the access for SILS (an Octo port) cost
$408.90, which was an NIC, to be paid by the patient, up
until December 2014. In 2015, this access device became
approved as an IC, so it was thereafter partly reimbursed by
the NHIC. Anesthesia fees were fixed for the first hour, and
increased in a manner proportional to the operation time.
Fees for preoperative diagnoses were composed of the
costs for laboratory studies, colonoscopies, and imaging
studies. A colonoscopy before surgery was not performed if
the patient had received a colonoscopy at a private clinic
and its quality was satisfactory. However, endoscopic tat-
tooing via a colonoscopy was performed when the tumor
seemed to be a T1 or T2 lesion and could not be found
laparoscopically. Imaging studies included abdominal
computed tomography (CT) and chest CT. Positron emission
tomography was not routinely performed except in cases
where metastatic colon cancer was suspected.
Fees for postoperative management included costs of
the hospital room, diet, medications, laboratory and im-
aging studies, transfusions, and consultations. These fees
included the costs associated with management of the early
postoperative complications that occurred during hospi-
talization. “Other” costs included fees for consultations byDownloaded for Anonymous User (n/a) at Yonsei University College
For personal use only. No other uses without permissionother departments, the issuing of medical documents,
rehabilitation, and other costs associated with post-
operative management. Costs that can be incurred in the
Korean health care system have been described in detail in
previous studies, although those studies focused on costs
associated with rectal cancer.16,17 One USD was calculated
to be 1,125 won, according to the exchange rate from
August 2017.
2.3. Statistical analysis
Because costs could be biased if the baseline patient
characteristics in the two groups were not balanced, pro-
pensity score-matching with a ratio of 1:1 according to the
following nine variables was performed: sex, age, BMI,
alcohol intake, smoking, ASA physical status class, previous
abdominal surgery, combined resection, and pathological
stage. Continuous variables were compared using Student’s
t-tests, and categorical variables were compared using the
c2 tests or Fisher’s exact tests. P-values <0.05 were
considered statistically significant. Incremental cost-
effectiveness ratio (ICER) was calculated for significantly
different variables between two groups. All statistical an-
alyses were performed using the Statistical Package for the
Social Sciences (SPSS, version 20.0, Chicago, IL, USA).
3. Results
From July 2009 and September 2014, 152 patients under-
went SILS and 509 patients underwent CLS at our of Medicine from ClinicalKey.com by Elsevier on April 06, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
Table 1 Baseline patient characteristics.
Overall cohort After matching
Variable SILS (n Z 152) CLS (n Z 509) P SILS (n Z 144) CLS (n Z 144) P
Male sex 79 (52) 292 (57.4) 0.264 78 (54.2) 79 (54.9) >0.999
Age (years)* 62.7 (11.2) 61.8 (11.6) 0.405 62.8 (10.9) 62.4 (10.9) 0.754
BMI (kg/m2)* 23.4 (3.0) 23.1 (2.9) 0.297 23.2 (2.9) 23.4 (2.8) 0.505
Alcohol intake 64 (42.1) 254 (49.9) 0.097 62 (43.1) 61 (42.4) >0.999
Smoking 49 (32.2) 158 (31) 0.842 46 (31.9) 44 (30.6) 0.899
ASA class 0.795 0.675
I 51 (33.6) 158 (31) 48 (33.3) 51 (35.4)
II 73 (48) 266 (52.3) 69 (47.9) 69 (47.9)
III 27 (17.8) 81 (15.9) 27 (18.8) 24 (16.7)
IV 1 (0.7) 4 (0.8) 0 (0) 0 (0)
Previous abdominal surgery 31 (20.4) 100 (19.6) 0.908 31 (21.5) 29 (20.1) 0.885
Tumor location
Cecum 6 (3.9) 17 (3.3) <0.001 6 (4.2) 1 (0.7) 0.281
Ascending colon 28 (18.4) 159 (31.3) 26 (18.1) 29 (20.1)
Transverse colon 6 (3.9) 36 (7.1) 6 (4.2) 8 (5.6)
Descending colon 1 (0.7) 8 (1.6) 0 (0) 0 (0)
Sigmoid colon 111 (73) 289 (56.8) 106 (73.6) 106 (73.6)
Values in parentheses are percentages unless otherwise indicated; *values are means (S.D.s); ASA, American Society of Anesthesiolo-
gists; BMI, body mass index; CLS, conventional laparoscopic surgery; SILS, single-incision laparoscopic surgery.
Table 2 Perioperative outcomes.
Variable SILS
(n Z 144)
CLS
(n Z 144)
P
Operation time
(minutes)*
173.5 (59.0) 181.7 (63.3) 0.454
Combined resection 13 (9) 11 (7.6) 0.832
Total length of
incisions (cm)*
3.6 (0.8) 7.5 (0.9) <0.001
Length of hospital
stay (days)*
6.4 (3.1) 7.0 (2.7) 0.084
Early postoperative
complicationsa
18 (12.5) 22 (15.3) 0.736
Anastomotic leakage 1 (0.7) 0 (0)
Ileus 4 (2.8) 5 (3.5)
Intraabdominal
fluid collection
5 (3.5) 3 (2.1)
Wound infection 8 (5.6) 8 (5.6)
Others 0 (0%) 6 (4.2%)
Late postoperative
complicationsb
8 (5.6) 6 (4.2) 0.785
Anastomotic stenosis 1 (0.7) 0 (0)
Ileus 1 (0.7) 0 (0)
Incisional hernia 3 (2.1) 4 (2.8)
Small bowel
obstruction
3 (2.1) 2 (1.4)
Readmission 4 (2.8%) 4 (2.8%) >0.999
Values in parentheses are percentages unless otherwise indi-
cated; *values are means (S.D.s); CLS, conventional laparo-
scopic surgery; SILS, single-incision laparoscopic surgery.
Combined resection refers to cholecystectomies, hepatec-
tomies, and hysterectomies.
a Within 30 days of surgery.
b From 30 days after surgery to February 2018 (the final
560 C.W. Kim et al.institution. After propensity score-matching, there was no
difference in baseline characteristics between the SILS and
CLS groups (nZ 144 in each group, Table 1). The left colon
was a more common location for tumors than the right
colon in both groups (73.6% left vs. 26.4% right in both
groups). Perioperative outcomes, including operation time
and length of hospital stay, were similar in both groups
(Table 2). The total skin incision length was shorter in the
SILS group than in the CLS group (3.6 cm vs. 7.5 cm,
P < 0.001). Both early and late postoperative morbidity
rates were similar between the two groups. There were
four readmissions due to late complications in each group
(2.8% vs. 2.8%, P > 0.999).
The total hospital charges did not differ between the
two groups (Table 3). However, the NICs were higher in the
SILS group than in the CLS group ($3936.70 vs. $3489.87,
P < 0.001), whereas the ICs were not different between
groups. Consequently, the patients’ total hospital bill (5% of
the ICs þ 100% of the NICs) was also higher in the SILS group
than in the CLS group ($4184.82 vs. $3735.00, P < 0.001),
whereas the government’s bill was similar in both groups.
Specifically, the fees for anesthesia, preoperative diag-
nosis, postoperative management, and other costs were not
different between the two groups. The only difference was
in the cost of instruments and supplies component of the
operation fee ($3157.87 vs. $2810.67, P < 0.001). This
difference ($347.20) was an important factor contributing
to the difference in total hospital charges between the two
groups ($417.60), although this difference was not signifi-
cantly different. ICER for total incision length, which was
only different between the two groups, in ‘total hospital
charge’ and patient’s bill and government’s bill in ‘cost of
instruments and supplies’ were -$107.08/1 cm, -$109.70/
1 cm, and $80.64/1 cm, respectively.follow-up date).
Downloaded for Anonymous User (n/a) at Yonsei University College of Medicine from ClinicalKey.com by Elsevier on April 06, 2020.
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Table 3 Perioperative costs in United States dollars (1 USD Z 1,125 won).
Variable SILS (n Z 144) CLS (n Z 144) P
Total hospital charges 8770.40 (2440.12) 8352.80 (1964.20) 0.099
Insured charge 4833.77 (1582.35) 4862.91 (1475.52) 0.872
Noninsured charge 3936.70 (1003.38) 3489.87 (936.16) <0.001
Patient’s bill 4184.82 (1158.15) 3735.00 (1002.19) <0.001
Government’s bill 4585.65 (1538.51) 4617.80 (1397.46) 0.853
Operation 5325.57 (942.27) 4945.40 (708.58) <0.001
Surgery and treatment fee 2167.70 (449.09) 2134.73 (343.25) 0.486
Cost of instruments and supplies 3157.87 (623.89) 2810.67 (478.51) <0.001
Anesthesia 571.03 (168.45) 579.64 (124.16) 0.623
Preoperative diagnosis 936.95 (635.18) 899.10 (618.17) 0.610
Postoperative management 1858.69 (1058.64) 1892.22 (1137.17) 0.797
Other 81.46 (525.59) 36.43 (47.55) 0.308
Values are means (S.D.s); CLS, conventional laparoscopic surgery; SILS, single-incision laparoscopic surgery.
Cost of single-incision laparoscopy for colon cancer 561The additional costs incurred in eight patients due to
hospital readmission caused by late complications are listed
in the Table 4. Among them, seven patients received sur-
gery under general anesthesia (i.e. Clavien-Dindo grade
IIIb) and one received surgery under local anesthesia (i.e.
Clavien-Dindo grade IIIa). There was no difference in these
additional costs between the patients in the SILS group and
those in the CLS group.4. Discussion
The advantages of MIS, including fast recovery, shorter
total incision length, and less pain compared to open sur-
gery, are attractive to patients as well as surgeons. How-
ever, although favorable outcomes associated with SILS
have been observed, SILS has not become a widespread
option for colon cancer due to certain questions that
remain unanswered with solid evidence. For instance, it is
not yet clear whether the shorter total incision length with
SILS directly produces superior cosmetic results,11,15 which
may be resolved in the future using objective methods,
such as questionnaires about cosmetic results. It is likewise
unclear whether SILS is indicated for all patients because of
the technical difficulty of the procedure.12e14,18 Further-
more, the learning curve for SILS has not firmly been
established, and it is unclear whether novices, as well asTable 4 Additional costs associated with readmission due to la
SILS (n Z 144)
Length of hospital stay (days) 8.50 (1.29)
Total hospital charges 2383.08 (311.89)
Insured charge 1369.18 (101.47)
Noninsured charge 971.28 (195.49)
Patient’s bill 1082.35 (221.79)
Government’s bill 1300.73 (96.42)
Operation 1269.90 (165.70)
Anesthesia 122.70 (16.14)
Preoperative diagnosis 348.80 (96.73)
Postoperative management 641.68 (228.08)
Values are means (S.D.s); CLS, conventional laparoscopic surgery; SIL
Downloaded for Anonymous User (n/a) at Yonsei University College
For personal use only. No other uses without permissionMIS-experienced surgeons, can successfully perform the
procedure. In addition, little research exists comparing the
costs of SILS with those of CLS for colon cancer.19 Among
these issues, we have previously reported the learning
curves associated with SILS for right colectomies and
anterior resections for colon cancer.12e14 Here, we
attempted to objectively answer one of the remaining is-
sues: the costs of these procedures. We found that the
costs of SILS and CLS for colon cancer were similar for pa-
tients who underwent treatment during both short- and
long-term time periods.
Total hospital charges were not significantly different
between the SILS and CLS groups (Table 3). Fees for the
preoperative diagnosis were similar because the diagnostic
studies for colon cancer are the same for all patients at our
institution, regardless of the surgical method used (SILS,
CLS, robotic surgery, or open surgery). Anesthesia fees,
which were proportional to the operation time, were
similar because of the similar operation times associated
with SILS and CLS. Fees for postoperative management can
increase if the hospital stay is lengthened because of
complications, late resumption of a normal diet, or for
other reasons. However, these fees were also similar be-
tween the two groups, because the average postoperative
course did not differ between the groups.
Although it was not statistically significant, a small dif-
ference was noted in the total hospital charges betweente complications.
CLS (n Z 144) P
8.00 (2.44) 0.734
2288.33 (269.23) 0.662
1317.05 (85.23) 0.462
1013.90 (217.23) 0.780
1037.13 (198.99) 0.772
1251.20 (80.94) 0.462
1302.80 (121.89) 0.760
133.15 (17.45) 0.413
306.55 (38.41) 0.463
545.83 (245.68) 0.588
S, single-incision laparoscopic surgery.
 of Medicine from ClinicalKey.com by Elsevier on April 06, 2020.
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562 C.W. Kim et al.the SILS and CLS groups. This difference was due to a
combination of the difference in cost of the access device
for SILS compared with that used for CLS, and the unique
features of the Korean health care system. According to the
policies of the NHIC, which approves certain instruments or
techniques as ICs only after sufficient evidence has been
provided, the cost of the access device for SILS was clas-
sified as NIC until December 2014. By contrast, the costs of
trocars, used in CLS, were already approved as ICs in 2005.
Therefore, in the current study patients in the SILS group
paid 100% of the costs of the access device. In contrast,
patients in the CLS group paid only 5% of the costs of the
four or five trocars ($23.12 or $28.90, respectively). After
several reports verified the safety of SILS for colorectal
diseases, the NHIC approved the cost of the SILS access
device as an IC starting in 2015. Thereafter, the patients’
portion of the cost for the SILS device was reduced to
$20.44 (5% of $408.90). Thus, the costs of SILS and CLS
would be similar in studies conducted in 2015 and later.
This means that, as of 2015 in Korea, patients who want to
undergo SILS no longer have to pay $450 more to attain a
shorter total incision length than that associated with CLS.
In terms of rectal cancer, the overall costs have been
reported to be different than those associated with colon
cancer surgery.16,17 The surgery fee for rectal cancer was
higher than that of colon cancer in Korea, possibly due to
the difficulty of the procedure. The operation time for
rectal surgery was usually longer than that of colon surgery,
which consequently increases the fees associated with the
operation, anesthesia, and postoperative management.
A few previous reports have evaluated the costs of SILS
for various diseases. Beck and colleagues showed similar
clinical outcomes between SILS and CLS for cholecystec-
tomies, with a small, non-significant difference in cost
($746) between the two groups.20 In contrast, Leung et al.
showed that single-incision laparoscopic cholecystectomy
was associated with higher total hospital charges compared
with CLS in their prospective randomized trial.21 A small
study from the United Kingdom, in contrast, showed SILS to
be cost-effective for common pediatric surgeries, such as
appendectomies, nephrectomies, and oophorectomies.22
Moreover, there have been several studies comparing SILS
and single-incision robotic surgery.23
In contrast, few reports have assessed the costs of SILS
for colorectal diseases. Sulu et al. showed that the total
costs were not different between the SILS and CLS groups,
although SILS was associated with shorter operation time
and consequently lower anesthesia fee.24 However, malig-
nancies accounted for only 20% of their cohort. Unlike for
benign diseases, surgery for malignant diseases requires
extensive lymph node harvesting and sufficient resection of
the mesocolon to achieve better oncological outcomes. In
terms of treating malignancies, Fujii et al. suggested that
SILS was advantageous because of the lower cost of access
instruments ($580 SILS vs. $713 CLS).25 Although their
analysis identified the cost of trocars as the cause of this
difference, these authors did not present data on the total
hospital charges, so the overall causes of the cost differ-
ences remain unclear. Van der Linden and colleagues per-
formed a cost analysis of SILS and CLS and analyzed each
category of costs.19 They showed that the total costs ten-
ded to be higher with SILS than with CLS for patients in theirDownloaded for Anonymous User (n/a) at Yonsei University College of
For personal use only. No other uses without permission. Cearly period (although this difference was not statistically
significant), and that the costs became comparable in their
late period, as the experience of SILS accumulated and the
clinical outcomes associated with SILS improved. Some
clinicians have tried to reduce costs by building a glove port
instead of purchasing SILS access devices.26,27
In the current study, we found no difference in the costs
raised by late complications between patients who under-
went SILS and those who underwent CLS (Table 4). The
similar perioperative outcomes of SILS and CLS seemed to
yield similar costs. Given that SILS was superior to CLS with
regards to total incision length and potential cosmetic
benefit, and given the lack of difference in costs of the two
surgical methods, surgeons and patients can consider SILS
as a viable option for treating colon cancer, although
adequate indications were premises.
To our knowledge, this is the first study to make a
detailed comparison of the differences in costs of SILS and
CLS for treating colon cancer based on long-term follow-up
care. Our results not only consolidate evidence regarding
the safety of SILS, but also provide information regarding
the cost analysis of SILS, for treating this malignancy.
However, our study has limitations that should be noted.
First, although the possibility of allocation bias was reduced
by propensity score-matching, selection bias may be still
inevitable in this retrospective study. Second, the number
of patients included from a single institution was relatively
small. Third, relatively low BMI of the Asian patients,
although the selection of patients was not performed, was
an obstacle for general application of SILS, especially in
Western countries. Fourth, the study period encompassed
several years before 2015, so the cost analysis does not
fully reflect the current situation in Korea, as the SILS ac-
cess device is now approved as an IC by the NHIC. Future
studies are required to address this issue. Fifth, this is not a
cost-effectiveness study, which requires a certain statisti-
cal methods using some useful tools such as quality of life
questionnaires. However, the prospective data could not be
gained due to the retrospective nature. Last, the applica-
tion of our cost analysis, as well as clinical outcomes, to
areas outside Korea may be inappropriate, because each
country has its own unique health care system and there
could be differences in patient populations from Korea and
other parts of the world.
In conclusion, SILS appears to be safe in terms of peri-
operative and long-term outcomes compared with CLS.
Moreover, the costs of SILS for colon cancer were generally
similar to those of CLS. Therefore, SILS can be considered a
reasonable treatment option for colon cancer for selective
patients.Conflict of interest
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